Answers are grounded in this paper and cite their sources.
The spray drying of indomethacin produced a viscous liquid phase which then solidified to an amorphous glassy solid mass. This amorphous phase was physically unstable and converted on storage to crystalline indomethacin forms II and I. Co -spray drying indomethacin with up to 20% PVP also gave a fused amorphous solid. Apparent solubility and dissolution studies illustrated the higher energy of indomethacin in these systems. The presence of PVP in the solid retarded conversion of indomethacin to a crystalline phase, the effect increasing with increasing PVP content. Scanning electron microscopy revealed the growth, with time, of needle-like whiskers on the surface of the amorphous products. Co-spray drying indomethacin with more than 20% PVP resulted firstly in products composed of a fused network of spherical particles, then partially coalesced spheres and ultimately, above 25% PVP, in individual agglomerated microspherical particles. The spray drying of either naproxen, ketoprofen or ibuprofen did not result in the formation of an amorphous glassy solid, Co-spray drying with PVP led to reduced crystallinity; the size of the melting endotherm decreased with increasing PVP content and became absent at 50% PVP. As the PVP percentage increased a microspherical product also developed, but at PVP levels greater than that observed for indomethacin.
No takes yet. Share an insight, caveat, or question.
Corrigan et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: